Shionogi & Co Ltd (4507) – tečaj delnic in novice

Simboli Simboli	Cena	Sprememba	Odstotna sprememba	Trend	Prejšnja končna cena	Odpri	Visoka	Nizka	Promet	Tržna kapitalizacija
SIXB Materials SIXB Materials	SIXB −0,33%	1.087,89	−3,62	−0,33%	—	1.093,81	1.096,52	1.100,22	1.091,51	—	—
SIXC Communications SIXC Communications	SIXC −0,19%	608,93	−1,18	−0,19%	—	608,77	608,77	612,97	608,77	—	—
SIXE Energy SIXE Energy	SIXE +0,13%	1.239,59	+1,61	+0,13%	—	1.254,81	1.253,01	1.253,87	1.226,33	—	—
SIXI Industrials SIXI Industrials	SIXI −0,40%	1.737,69	−7,02	−0,40%	—	1.761,11	1.764,27	1.766,88	1.744,71	—	—
SIXM Financials SIXM Financials	SIXM −0,45%	637,33	−2,85	−0,45%	—	642,58	644,87	648,48	640,18	—	—
SIXR Staples SIXR Staples	SIXR −0,60%	844,51	−5,07	−0,60%	—	851,13	855,66	858,75	845,56	—	—
SIXRE Real estate SIXRE Real estate	SIXRE −0,44%	216,53	−0,95	−0,44%	—	217,98	217,98	218,65	216,88	—	—
SIXT Technology SIXT Technology	SIXT +0,53%	3.277,94	+17,25	+0,53%	—	3.211,83	3.227,21	3.268,38	3.226,55	—	—
SIXU Utilities SIXU Utilities	SIXU −0,39%	938,75	−3,70	−0,39%	—	948,98	948,58	957,83	941,97	—	—
SIXV Health care SIXV Health care	SIXV −0,51%	1.459,31	−7,49	−0,51%	—	1.474,52	1.479,03	1.481,04	1.466,80	—	—
SIXY Discretionary SIXY Discretionary	SIXY −0,13%	2.394,46	−3,04	−0,13%	—	2.392,12	2.396,95	2.421,22	2.382,32	—	—

4507:TYO

Shionogi & Co Ltd

3.128,00 ¥

−1,32%

(−42,00) 1D

1. maj, 15:30:00 GMT +9 · JPY

Vsi simboli

TLDD

MAKS

	Simbol	Cena	Sprememba	Odstotna sprememba

Generiranje najpomembnejših vpogledov za 4507 …

Odpri

3.172 ¥

Visoka

3.174 ¥

Nizka

3.112 ¥

Tržna kapitalizacija

2,78 bil.

Povprečni promet

2,82 mio.

Promet

2,33 mio.

Dividenda

2,11 %

Četrtletna dividenda

16 ¥

Prvi trgovalni dan brez upravičenja do dividende

29. sep. 2025

Razmerje med ceno delnice in čistim dobičkom

13,66

52-tedenski najvišji tečaj

3.758 ¥

52-tedenski najnižji tečaj

2.162 ¥

Čisti dobiček na delnico

229 ¥

Št. izdanih delnic

314,50 mio.

Št. zaposlenih

5 tis.

Podobne delnice

Sumitomo Pharma Co Ltd

1.729,50 ¥

+0,58%

4568

Daiichi Sankyo Co Ltd

Novice

Iz virov v spletu

Stock Titan

pred 8 minutami

A $20M Lunai deal adds two routes past the blood-brain barrier

TheStreet

pred 13 minutami

Citi’s data could change how you invest at S&P 500 highs

AOL.com

pred 14 minutami

Veeva Systems Just Joined the S&P 500. 3 Reasons to Buy It and 1 Not To.

TipRanks

pred 19 minutami

Copel Joins Dow Jones Best-in-Class Index for Global ESG Performance

Profil

Shionogi & Company, Limited is a Japanese pharmaceutical company best known for developing Crestor. Medical supply and brand name also uses katakana. Shionogi has business roots that date back to 1878, and was incorporated in 1919. Among the medicines produced are for hyperlipidaemia, antibiotics, and cancer medicines. In Japan it is particularly known as a producer of antimicrobial and antibiotics. Because of antibiotic resistance and slow growth of the antibiotic market, it has teamed up with US based Schering-Plough to become a sole marketing agent for its products in Japan. Shionogi had supported the initial formation of Ranbaxy Pharmaceuticals, a generic manufacturer based in India. In 2012 the company became a partial owner of ViiV Healthcare, a pharmaceutical company specialising in the development of therapies for HIV. The company is listed on the Tokyo Stock Exchange and Osaka Securities Exchange and is constituent of the Nikkei 225 stock index. In June 2023, Shionogi announced its acquisition of Qpex Biopharma for approximately $140m. Wikipedia

Vizitka: Shionogi & Co Ltd

Generalni direktorIsao Teshirogi

Št. zaposlenih4,96 tis.

Ustanovljeno1878

SedežOsaka, Prefektura Osaka, Japonska

Sektor-

Spletno mestoshionogi.com

Vse vrednosti v valuti JPY	mar. 2025	jun. 2025	sep. 2025	dec. 2025
Prihodek	104,67 mrd.	99,78 mrd.	113,18 mrd.	147,72 mrd.
Strošek prodanega blaga	17,79 mrd.	12,32 mrd.	16,94 mrd.	25,09 mrd.
Stroški materiala in storitev	17,79 mrd.	12,32 mrd.	16,94 mrd.	25,09 mrd.
Stroški raziskav in razvoja	29,16 mrd.	24,89 mrd.	27,55 mrd.	29,87 mrd.
Skupni stroški raziskav in razvoja	-	-	-	-
Stroški prodaje, splošni in administrativni stroški	23,87 mrd.	25,82 mrd.	27,56 mrd.	35,27 mrd.
Operativni strošek	56,78 mrd.	52,37 mrd.	56,57 mrd.	48,45 mrd.
Skupni operativni stroški	74,57 mrd.	64,68 mrd.	73,51 mrd.	73,54 mrd.
Prihodek iz poslovanja	30,10 mrd.	35,10 mrd.	39,67 mrd.	74,18 mrd.
Drug prihodek, ki ne izhaja iz poslovanja	−1,14 mrd.	−1,00 mio.	-	−1,00 mio.
Zaslužek pred obdavčitvijo z vključenimi izrednimi postavkami	44,87 mrd.	46,33 mrd.	52,06 mrd.	92,89 mrd.
Zaslužek pred obdavčitvijo brez izrednih postavk	53,35 mrd.	46,33 mrd.	52,06 mrd.	93,10 mrd.
Odhodek iz obdavčitve dobička	8,68 mrd.	6,98 mrd.	7,87 mrd.	18,21 mrd.
Dejanska davčna stopnja	19,33 %	15,07 %	15,12 %	19,60 %
Drugi operativni stroški	−2,00 mrd.	1,17 mrd.	979,00 mio.	−17,25 mrd.
Čisti prihodek	36,63 mrd.	39,36 mrd.	44,19 mrd.	74,68 mrd.
Neto stopnja dobička	35,00 %	39,44 %	39,04 %	50,56 %
Čisti dobiček na delnico	-	-	-	-
Prihodki iz obresti in naložb	25,40 mrd.	13,56 mrd.	14,21 mrd.	20,53 mrd.
Obrestni odhodki	-	−2,33 mrd.	−1,82 mrd.	−1,61 mrd.
Neto obrestni odhodki	25,40 mrd.	11,23 mrd.	12,38 mrd.	18,92 mrd.
Stroški amortizacije	−3,26 mrd.	-	−485,00 mio.	-
EBITDA	35,30 mrd.	40,11 mrd.	44,83 mrd.	80,21 mrd.
Dobiček ali izguba pri prodaji sredstev	254,00 mio.	-	-	-

Vsebina z UI lahko vsebuje napake. Več o tem

PomočPošljite povratne informacijeZasebnost Pogoji Zavrnitev odgovornosti

Finance

Raziskovanje